Cargando…

Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome

White adipose tissue (WAT) is an endocrine organ highly integrated in homeostasis and capable of establishing ways of communicating and influencing multiple metabolic processes. Brown adipose tissue promotes energy expenditure by incorporating the uncoupling protein 1 (UCP1), also known as thermogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Arhire, Lidia I., Mihalache, Laura, Covasa, Mihai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687775/
https://www.ncbi.nlm.nih.gov/pubmed/31428053
http://dx.doi.org/10.3389/fendo.2019.00524
_version_ 1783442777541967872
author Arhire, Lidia I.
Mihalache, Laura
Covasa, Mihai
author_facet Arhire, Lidia I.
Mihalache, Laura
Covasa, Mihai
author_sort Arhire, Lidia I.
collection PubMed
description White adipose tissue (WAT) is an endocrine organ highly integrated in homeostasis and capable of establishing ways of communicating and influencing multiple metabolic processes. Brown adipose tissue promotes energy expenditure by incorporating the uncoupling protein 1 (UCP1), also known as thermogenin, which decouples cellular respiration and heat production, in the mitochondrial membranes. Recent data suggest the presence of a thermogenic cell formation from white adipocytes (beige or brite cells) with a potential role in preventing obesity and metabolic syndrome. The formation of these cells is influenced by physical exertion that induces expression of PPARγ coactivator-1 (PGC1) and downstream membrane protein, fibronectin type III domain-containing protein 5 (FNDC5) in skeletal muscle. Irisin, a thermogenic adipomyokine produced by FNDC5 cleavage is involved in the browning of adipose tissue. While animal studies are congruent with regard to the relationship between physical exertion and irisin release, the results from human studies are less than clear. Therefore, this review focuses on recent advances in our understanding of muscle and adipose tissue thermogenesis. Further, it describes the molecular mechanisms by which irisin impacts exercise, glucose homeostasis and obesity. Finally, the review discusses current gaps and controversies related to irisin release, its mode of action and its future potential as a therapeutic tool in managing obesity and metabolic syndrome.
format Online
Article
Text
id pubmed-6687775
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66877752019-08-19 Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome Arhire, Lidia I. Mihalache, Laura Covasa, Mihai Front Endocrinol (Lausanne) Endocrinology White adipose tissue (WAT) is an endocrine organ highly integrated in homeostasis and capable of establishing ways of communicating and influencing multiple metabolic processes. Brown adipose tissue promotes energy expenditure by incorporating the uncoupling protein 1 (UCP1), also known as thermogenin, which decouples cellular respiration and heat production, in the mitochondrial membranes. Recent data suggest the presence of a thermogenic cell formation from white adipocytes (beige or brite cells) with a potential role in preventing obesity and metabolic syndrome. The formation of these cells is influenced by physical exertion that induces expression of PPARγ coactivator-1 (PGC1) and downstream membrane protein, fibronectin type III domain-containing protein 5 (FNDC5) in skeletal muscle. Irisin, a thermogenic adipomyokine produced by FNDC5 cleavage is involved in the browning of adipose tissue. While animal studies are congruent with regard to the relationship between physical exertion and irisin release, the results from human studies are less than clear. Therefore, this review focuses on recent advances in our understanding of muscle and adipose tissue thermogenesis. Further, it describes the molecular mechanisms by which irisin impacts exercise, glucose homeostasis and obesity. Finally, the review discusses current gaps and controversies related to irisin release, its mode of action and its future potential as a therapeutic tool in managing obesity and metabolic syndrome. Frontiers Media S.A. 2019-08-02 /pmc/articles/PMC6687775/ /pubmed/31428053 http://dx.doi.org/10.3389/fendo.2019.00524 Text en Copyright © 2019 Arhire, Mihalache and Covasa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Arhire, Lidia I.
Mihalache, Laura
Covasa, Mihai
Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title_full Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title_fullStr Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title_full_unstemmed Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title_short Irisin: A Hope in Understanding and Managing Obesity and Metabolic Syndrome
title_sort irisin: a hope in understanding and managing obesity and metabolic syndrome
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687775/
https://www.ncbi.nlm.nih.gov/pubmed/31428053
http://dx.doi.org/10.3389/fendo.2019.00524
work_keys_str_mv AT arhirelidiai irisinahopeinunderstandingandmanagingobesityandmetabolicsyndrome
AT mihalachelaura irisinahopeinunderstandingandmanagingobesityandmetabolicsyndrome
AT covasamihai irisinahopeinunderstandingandmanagingobesityandmetabolicsyndrome